登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C35H60N2O4 · Br2
化学文摘社编号:
分子量:
732.67
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
SMILES string
[Br-].[Br-].[N+]6(CCCCC6)([C@@H]1[C@@H]([C@@]2([C@H]([C@H]3[C@@H]([C@@]4([C@H](C[C@@H]([C@H](C4)[N+]5(CCCCC5)C)OC(=O)C)CC3)C)CC2)C1)C)OC(=O)C)C
InChI
1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1
InChI key
NPIJXCQZLFKBMV-YTGGZNJNSA-L
assay
≥98% (NMR)
form
solid
potency
5.5 nM IC50
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
off-white
solubility
water: 100 mM
Quality Level
General description
A highly potent competitive antagonist selective for nAChRs (IC50 = 5.5 nM). A very potent non-depolarizing skeletal muscle relaxant but no sedative or analgesic effects.
Biochem/physiol Actions
Primary Target
nAChR
nAChR
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Other Notes
Lowenick et al., 2001. Eur. J. Pharmacol.413, 31.
Melnikov, L., et al., 1999. Gen Pharmacol.33, 313.
Maestrone, E., et al., 1994. Br. J. Pharmacol.111, 283.
Fryer, D., et al., 1987. Naunyn Schmiedebergs Arch. Pharmacol.335, 367.
Melnikov, L., et al., 1999. Gen Pharmacol.33, 313.
Maestrone, E., et al., 1994. Br. J. Pharmacol.111, 283.
Fryer, D., et al., 1987. Naunyn Schmiedebergs Arch. Pharmacol.335, 367.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Toxic (F)
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
存储类别
6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持